The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation.
J Pharmacol Exp Ther
; 310(3): 1053-61, 2004 Sep.
Article
em En
| MEDLINE
| ID: mdl-15159442
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Fenantrenos
/
Adjuvantes Imunológicos
/
Encefalomielite Autoimune Experimental
/
Inibidores de Poli(ADP-Ribose) Polimerases
Idioma:
En
Ano de publicação:
2004
Tipo de documento:
Article